Citations

Mayo Clinic

Clear

2500 citation(s) found for "Ma, C Benjamin".

Arthroscopic Labral Reconstruction of the Hip Using Semitendinosus Allograft
Redmond, John M., Cregar, William M., Martin, Timothy J. , Vemula, S. Pavan, Gupta, Asheesh, Domb, Benjamin G.

Arthroscopy Techniques | July 27, 2015 | Volume: 4 | Issue: 4 | Pages: No page available

10.1016/j.eats.2015.03.002 | PMID 26759770 Get It

Abstract The labrum of the hip is recognized as being important to the stability of the hip and a major cause of hip pain. Damage to the labrum may result in increased joint stress and articular damage. Labral damage is often treated through various methods, among them simple stitch repair, base refixation, and debridement. Labral reconstruction becomes necessary when the labrum is too damaged to salvage, which renders labral repair improbable and labral debridement ineffective. In contrast to other methods that have been described for this treatment, our technique uses a semitendinosus allograft as a graft source, allowing for arthroscopic hip labral reconstruction. This technique has many advantages and is easily reproducible. It has shown promising results in patients with labral damage. The purpose of this article is to detail the step‐by‐step surgical technique of labral reconstruction using a semitendinosus allograft, in addition to the indications, pearls, and pitfalls of the technique. Technique Video video See video under supplementary data.
Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a NovelBEST1Mutation
Johnson, Adiv A. , Bachman, Lori A. , Gilles, Benjamin, Cross, Samuel D., Stelzig, Kimberly E. , Resch, Zachary T., Marmorstein, Lihua Y., Pulido, José S. , Marmorstein, Alan D. , Gilles, Benjamin J, Stelzig, Kimberly E. , Marmorstein, Alan D

Investigative Opthalmology & Visual Science | July 22, 2015 | Volume: 56 | Issue: 8 | Pages: 4619

10.1167/iovs.15-16910 | PMID 26200502 Get It

Massive Hepatic Parenchymal and Portal Venous Gas
Barbara, David W. , Comfere, Thomas B., Broski, Stephen M. , Smith, Benjamin Carl

Anesthesiology | July 8, 2015 | Volume: 124 | Issue: 1 | Pages: 184-184

10.1097/aln.0000000000000772 | PMID 26154187 Get It

Abstract Supplemental Digital Content is available in the text.
Seronegative infections in hip and knee arthroplasty
McArthur, Benjamin A., Taunton, Michael J. , Osmon, Douglas R. , Hanssen, Arlen D. , Abdel, Matthew P. , Taunton, Michael J

The Bone & Joint Journal | June 30, 2015 | Volume: 97-B | Issue: 7 | Pages: 939-944

10.1302/0301-620x.97b7.35500 | PMID 26130349 Get It

The aim of our study was to describe the characteristics, treatment, and outcomes of patients with periprosthetic joint infection (PJI) and normal inflammatory markers after total knee arthroplasty (TKA) and total hip arthroplasty (THA).In total 538 TKAs and 414 THAs underwent surgical treatment for PJI and met the inclusion criteria. Pre-operative erythrocyte sedimentation rate (ESR) and C-reactive protein level (CRP) were reviewed to identify the seronegative cohort. An age- and gender-matched cohort was identified from the remaining patients for comparison. Overall, 4% of confirmed infections were seronegative (21 TKA and 17 THA). Of those who underwent pre-operative aspiration, cultures were positive in 76% of TKAs (n = 13) and 64% of THAs (n = 7). Cell count and differential were suggestive of infection in 85% of TKA (n = 11) and all THA aspirates (n = 5). The most common organism was coagulase-negative Staphylococcus. Seronegative infections were associated with a lower aspirate cell count and a lower incidence of Staphylococcus aureus infection. Two-stage revision was performed in 35 cases (95%). At a mean of five years (14 to 162 months) following revision, re-operation for infection occurred in two TKAs, and one THA. From our study we estimate around 4% of patients with PJI may present with normal ESR and CRP. When performed, pre-operative aspirate is useful in delivering a definitive diagnosis. When treated, similar outcomes can be obtained compared with patients with positive serology.Cite this article: Bone Joint J 2015;97-B:939–44.
Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder
Kemp, David E. , Friedman, Edward S., Reilly-Harrington, Noreen A. , Sylvia, Louisa G. , Calabrese, Joseph R. , Rabideau, Dustin J. , Ketter, Terence A. , Thase, Michael E., Tohen, Mauricio , Bowden, Charles L., Brody, Benjamin D. , Deckersbach, Thilo , Kocsis, James H., Kinrys, Gustavo , Kamali, Masoud , McInnis, Melvin G. , Leon, Andrew C. , Faraone, Stephen V. , Nierenberg, Andrew A. , Shelton, Richard C. , McElroy, Susan L. , Singh, Vivek Kumar , Bernstein, Emily E. , Bobo, William V. , Kamali, Masoud , McInnis, Melvin G

Acta Psychiatrica Scandinavica | June 26, 2015 | Volume: 133 | Issue: 2 | Pages: 144-153

10.1111/acps.12460 | PMID 26114830 Get It

ObjectiveExamine the effects of obesity and metabolic syndrome on outcome in bipolar disorder.MethodThe Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer and a Classic Mood Stabilizer for Bipolar Disorder (Bipolar CHOICE) study randomized 482 participants with bipolar disorder in a 6‐month trial comparing lithium‐ and quetiapine‐based treatment. Baseline variables were compared between groups with and without obesity, with and without abdominal obesity, and with and without metabolic syndrome respectively. The effects of baseline obesity, abdominal obesity, and metabolic syndrome on outcomes were examined using mixed effects linear regression models.ResultsAt baseline, 44.4% of participants had obesity, 48.0% had abdominal obesity, and 27.3% had metabolic syndrome; neither obesity, nor abdominal obesity, nor metabolic syndrome were associated with increased global severity, mood symptoms, or suicidality, or with poorer functioning or life satisfaction. Treatment groups did not differ on prevalence of obesity, abdominal obesity, or metabolic syndrome. By contrast, among the entire cohort, obesity was associated with less global improvement and less improvement in total mood and depressive symptoms, suicidality, functioning, and life satisfaction after 6 months of treatment. Abdominal obesity was associated with similar findings. Metabolic syndrome had no effect on outcome.ConclusionObesity and abdominal obesity, but not metabolic syndrome, were associated with less improvement after 6 months of lithium‐ or quetiapine‐based treatment.
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Yang, Ju Dong , Campion, Michael B., Liu, Minetta C. , Chaiteerakij, Roongruedee , Giama, Nasra H., Mohammed, Hager Ahmed, Hu, Chunling , Campion, Victoria, Jen, Jin , Venkatesh, Sudhakar K. , Halling, Kevin C. , Kipp, Benjamin R. , Roberts, Lewis R. , Ahmed Mohammed, Hager, Campion, Victoria L, Yang, Ju Dong , Chaiteerakij, Roongruedee , Zhang, Xiaodan , Roberts, Lewis R , Venkatesh, Sudhakar K , Hu, Chunling

Hepatology | June 19, 2015 | Volume: 63 | Issue: 1 | Pages: 148-158

10.1002/hep.27944 | PMID 26096702 Get It

Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are associated with poor survival of patients with cholangiocarcinoma (CCA). Eighty‐eight patients with CCA were prospectively enrolled at Mayo Clinic Rochester between June 2010 and September 2014. The CellSearch system by Veridex was used for detection of CTCs in peripheral blood. Associations between CTC, patient and tumor characteristics, and survival were examined using the Cox's proportional hazards model. Fifteen patients (17%) were positive for CTC ≥2 and 8 patients (9%) for CTC ≥5. CTCs were associated with tumor extent. CTC ≥2 (hazard ratio [HR]: 2.5; 95% confidence interval [CI]: 1.1‐5.4; P = 0.02) and CTC ≥5 (HR, 4.1; 95% CI: 1.4‐10.8; P = 0.01) were both independent predictors of survival. In subgroup analyses, CTC ≥2 (HR, 8.2; 95% CI: 1.8‐57.5; P < 0.01) and CTC ≥5 (HR, 7.7; 95% CI: 1.4‐42.9; P = 0.02) were both associated with shorter survival among patients with metastasis. There was a trend toward association of CTC ≥5 with shorter survival in patients with nonmetastatic CCA (HR, 4.3; 95% CI: 1.0‐13.8; P = 0.06). CTC ≥2 (HR, 10.5; 95% CI: 2.2‐40.1; P < 0.01) and CTC ≥5 (HR, 10.2; 95% CI: 1.5‐42.3; P = 0.02) were both associated with shorter survival among patients with perihilar/distal CCA. CTC ≥5 was associated with shorter survival of patients with intrahepatic CCA (HR, 4.2; 95% CI: 1.1‐14.1; P = 0.04). Conclusion: CTCs were associated with more‐aggressive tumor characteristics and independently associated with survival in patients with CCA. Assessment of CTCs may be useful for identifying CCA patients at risk of early mortality. (Hepatology 2016;63:148–158)
Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma
Brankley, Shannon M., Halling, Kevin C. , Jenkins, Sarah M. , Timmer, Margriet R., Iyer, Prasad G. , Smyrk, Thomas C. , Voss, Jesse S. , Kipp, Benjamin R. , Campion, Michael B., Lutzke, Lori S., Minot, Douglas M., Wang, K. K., Fritcher, Emily G. Barr , Wang, Kenneth K

Diseases of the Esophagus | June 5, 2015 | Volume: 29 | Issue: 6 | Pages: 513-519

10.1111/dote.12372 | PMID 26043762 Get It

Lymphadenopathy With Ipsilateral Eye Involvement
Acheampong, Benjamin , Loar, Robert W. , Boyce, Thomas G.

Clinical Pediatrics | May 27, 2015 | Volume: 54 | Issue: 9 | Pages: 910-912

10.1177/0009922815588824 | PMID 26016836 Get It